- Product Details
Keywords
- FMOC-L-Aspartic acid beta-tert-butyl ester suppiler
- FMOC-L-Aspartic acid beta-tert-butyl ester
- high quality FMOC-L-Aspartic acid beta-tert-butyl ester
Quick Details
- ProName: FMOC-L-Aspartic acid beta-tert-butyl e...
- CasNo: 71989-14-5
- Molecular Formula: C23H25NO6
- Appearance: Detailed see specifications
- Application: fine chemicals,intermeidates
- DeliveryTime: Depend on the quantity client want
- PackAge: According to client's requirements
- Port: SHANGHAI,CHINA
- ProductionCapacity: 50 Metric Ton/Month
- Purity: 98.0%
- Storage: keep sealed and keep from direct light
- Transportation: According to client's requirements
- LimitNum: 10 Gram
- Moisture Content: send with COA
- Impurity: send with COA
Superiority
Product name: n-α-Fmoc-L-aspartic acid β-t.-butyl este.
Synonym:Fmoc-(tBu)Asp-OH;cas:71989-14-5;Fmoc-L-asparticacidβ-tert-butylester≥99.7%(HPLC,Chiralpurity);N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-ASPARTICACIDBETA-T-BUTYLESTER;N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-ASPARTICACIDBETA-TERT-BUTYLESTER;N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-ASPARTICACIDBETA-T-BUTYLESTER;N-9-FLUORENYLMETHYLOXYCARBONYL-L-ASPARTICACIDBETA-T-BUTYLESTER;N-9-FLUORENYLMETHYLOXYCARBONYL-L-ASPARTICACIDBETA-TERT-BUTYLESTER
CAS No: 71989-14-5.
Molecular formula: C23H25NO6.
Molecular weight: 411.45.
Melting point: 148150 °C (dec.).
Specific optical rotation:-25 °(cym1, DMF24 °C).
Boiling point: 530.45 °C (roughestimate).
Density: 1.2498 (roughestimate).
Refractive index:-25 °.
Storage condition: 2-8 °C.
Acidity coefficient (pKa): 3.57 ±0.23 (Predicted).
Optical activity (opticalactivity): [α] 20/D24 ±2 °, c=1%inDMF.
Water solubility: Slightlysolubleinwater.
Details
Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization. Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.
It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.